Gregory Young
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Global Cancer Incidence and Screening
- Cytokine Signaling Pathways and Interactions
- Cancer Cells and Metastasis
- Immunology top 5%
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 38
- Global Cancer Incidence and Screening 14
- Colorectal Cancer Screening and Detection 12
- Cancer Immunotherapy and Biomarkers 5
- Immunology 18
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 5
- Co-authors
- Gregory B. Lesinski (29 shared papers)Thomas A. Mace (17 shared papers)Electra D. Paskett (35 shared papers)Tanios Bekaii‐Saab (9 shared papers)Mark Bloomston (8 shared papers)Matthew A. Bill (8 shared papers)James R. Fuchs (5 shared papers)William E. Carson (10 shared papers)
- Journals
- Cancer Research (8 papers)Cancer Epidemiology Biomarkers & Prevention (7 papers)PLoS ONE (4 papers)Molecular Cancer Therapeutics (4 papers)Health Affairs (4 papers)
- Partner nations
- United StatesVietnamIndia
In The Last Decade
Gregory Young
130 papers receiving 4.1k citations
Gregory Young's Hit Papers
Peers
Comparison fields: 5 of 159
- Oncology 1.4k
- Immunology 863
- Biochemistry 200
- Molecular Medicine 104
- Rheumatology 252
Countries citing papers authored by Gregory Young
This map shows the geographic impact of Gregory Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Young more than expected).
Fields of papers citing papers by Gregory Young
This network shows the impact of papers produced by Gregory Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Young. The network helps show where Gregory Young may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory Young, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer Hit paper breakdown → | 2016 | 414 |
| 2 | 2013 | 355 | |
| 3 | 2011 | 160 | |
| 4 | 1998 | 125 | |
| 5 | 2011 | 111 | |
| 6 | 2003 | 107 | |
| 7 | 2010 | 105 | |
| 8 | 2006 | 89 | |
| 9 | 2009 | 85 | |
| 10 | 2012 | 82 | |
| 11 | 2010 | 81 | |
| 12 | 2014 | 78 | |
| 13 | 2012 | 77 | |
| 14 | 2013 | 75 | |
| 15 | 2015 | 73 | |
| 16 | 2008 | 70 | |
| 17 | 2013 | 67 | |
| 18 | 1993 | 63 | |
| 19 | 2012 | 58 | |
| 20 | The use of sulfasalazine in psoriatic arthritis: a clinic experience. | 1998 | 58 |
About Gregory Young
Gregory Young is a scholar working on Oncology, Immunology, Molecular Biology, Pathology and Forensic Medicine and Epidemiology, having authored 135 papers that have together received 4.2k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (14 papers), Colorectal Cancer Screening and Detection (12 papers), Cervical Cancer and HPV Research (5 papers), Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Skin Protection and Aging (5 papers), Immune cells in cancer (5 papers) and Genetic Neurodegenerative Diseases (5 papers). The work is most often cited by research in Oncology (1.4k citations), Immunology (863 citations), Biochemistry (200 citations), Molecular Medicine (104 citations) and Rheumatology (252 citations). Gregory Young has collaborated with scholars based in United States, Vietnam and India. Frequent co-authors include Gregory B. Lesinski, Thomas A. Mace, Electra D. Paskett, Tanios Bekaii‐Saab, Mark Bloomston, Matthew A. Bill, James R. Fuchs, William E. Carson, Steven K. Clinton and Zeenath Ameen. Their work appears in journals such as Cancer Research, Cancer Epidemiology Biomarkers & Prevention, PLoS ONE, Molecular Cancer Therapeutics and Health Affairs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.